Rehabilitation of Individuals With Diabetes Mellitus: Focus on Diabetic Myopathy.
Bassi-Dibai D, Santos-de-Araújo AD, Dibai-Filho AV, de Azevedo LFS, Goulart CDL, Luz GCP, Burke PR, Garcia-Araújo AS, Borghi-Silva A.
Front Endocrinol (Lausanne). 2022 Apr 14;13:869921. doi: 10.3389/fendo.2022.869921. eCollection 2022.
PMID:35498435
The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes.
Karaa A, Goldstein A.
Pediatr Diabetes. 2015 Feb;16(1):1-9. doi: 10.1111/pedi.12223. Epub 2014 Oct 20.
PMID:25330715
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association.
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL 2nd, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK; American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council.
Endothelin-1-mediated miR-let-7g-5p triggers interlukin-6 and TNF-alpha to cause myopathy and chronic adipose inflammation in elderly patients with diabetes mellitus.
Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction.
Lee SJ.
J Clin Invest. 2021 May 3;131(9):e148372. doi: 10.1172/JCI148372.
PMID:33938454
Human skeletal muscle CD90(+) fibro-adipogenic progenitors are associated with muscle degeneration in type 2 diabetic patients.
Farup J, Just J, de Paoli F, Lin L, Jensen JB, Billeskov T, Roman IS, Cömert C, Møller AB, Madaro L, Groppa E, Fred RG, Kampmann U, Gormsen LC, Pedersen SB, Bross P, Stevnsner T, Eldrup N, Pers TH, Rossi FMV, Puri PL, Jessen N.
Cell Metab. 2021 Nov 2;33(11):2201-2214.e11. doi: 10.1016/j.cmet.2021.10.001. Epub 2021 Oct 21.